一分钟看懂
这是一项关于多发性骨髓瘤的I 期 / II 期研究，登记的药物或干预包括LBL-034 for Injection，当前状态为招募中。登记地点显示中国芜湖、北京、厦门、广州等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
LBL-034 for Injection · I 期 / II 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- The First Affiliated Hospital of Wannan Medical College · 芜湖
- Peking University People's Hospital · 北京
- The First Affiliated Hospital of Xiamen University · 厦门
- Sun Yat-sen University Cancer Center · 广州
- Shenzhen Second People's Hospital · 深圳
- The Afliliated Hospital of Guizhou Medical Univeristy · 贵阳
- The Second Affiliated Hospital of Hainan Medical University · 海口
- The First Affiliated Hospital of Henan University · 洛阳
- Henan Cancer Hospital · 郑州
- The First Affiliated Hospital of Zhengzhou University · 郑州
- Union Hospital Tongji Medical College Huazhong University of Science and Technology · 武汉
- The First Affiliated Hospital of Soochow University · 苏州
- The First Bethune Hospital of Jilin University · 长春
- Shengjing Hospital of China Medical University · 沈阳
- Qingdao Municipal Hospital · 青岛
- Shanghai Fourth People's Hospital · 上海
- Shanxi Bethune Hospital · 太原
- The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital) · 西安
- The First Affiliated Hospital Zhejiang University School of Medicine · 杭州
- The First Affiliated Hospital of Ningbo University · 宁波
- The First Affiliated Hospital of Wenzhou Medical University · 温州
公开的入选条件
- 1. Agree to follow the trial treatment regimen and visit schedule, voluntarily enroll in the study, and sign the written informed consent form;
- 2. Age ≥ 18 years at the time of signing the informed consent;
- 3. Eastern Cooperative Oncology Group (ECOG) Performance Status Scale≤ 1；
- 4. Documentation of initial diagnosis of multiple myeloma according to IMWG diagnostic criteria,or according to the IMWG 2021 diagnostic criteria, the proportion of circulating plasma cells in peripheral blood is ≥ 5%,have documentation to diagnose PCL；
- 5. Have a life expectancy of at least 12 weeks；
- 6. Fertile men and women of childbearing age are willing to take effective contraceptive measures (including abstinence, intrauterine devices, hormonal contraception, and correct use of condoms) from the signing of the informed consent form to 6 months after t
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT06049290；登记信息更新于 2026-09-11。